Company / Operating Income per Share
Moderna Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$7.96
FY2025
5-year range
-$11.01 / -$1.37
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
#188 of 201
Health Care
What the data says
Among 201 Health Care companies, Moderna is in the bottom 6% for operating income per share. Operating Income per Share has fluctuated over the past 10 years, ranging from $-11.01 in FY2023 to $-1.37 in FY2021.
Based on SEC 10-K filings.
-7.96 in FY2025.
Improved from $-11.01 to $-7.96 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 201This company -$7.96 Sector average -$28.56
▼
+72.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 22.9% year-over-year.
- Ranks #188 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.96 | +22.9% |
| FY2024 | -$10.33 | +6.2% |
| FY2023 | -$11.01 | -481.5% |
| FY2022 | -$1.89 | -38.4% |
| FY2021 | -$1.37 | +39.6% |
| FY2020 | -$2.27 | -36.5% |
| FY2019 | -$1.66 | +73.8% |
| FY2018 | -$6.34 | -51.8% |
| FY2017 | -$4.18 | -13.4% |
| FY2016 | -$3.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026